Impairment of health‐related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium
- 17 July 2023
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (11) , e30560
Abstract
Background: Children treated for acute lymphoblastic leukemia (ALL) receive prolonged treatment, resulting in toxicities that affect health‐related quality of life (HR‐QoL). Longitudinal assessment of HR‐QoL allows improved understanding of experiences with ALL.Procedure: Parent‐proxy and child self‐report HR‐QoL over the first year of chemotherapy were evaluated in the context of DFCI Protocol 05‐001, a phase 3 therapeutic trial for childhood ALL. HR‐QoL was assessed with the Pediatric Quality‐of‐Life inventory (PedsQL) domains for Pain and Hurt, Procedural Anxiety, Treatment Anxiety, Emotional Functioning, General Fatigue, and Sleep/Rest Fatigue.Results: Total of 281 subjects participated, with 141 contributing at least one child report and 280 at least one parent report. Children with ALL experienced impairment in HR‐QoL by both patient and parent report compared to the published PedsQL reference population at each time point on each subscale. Agreement between parent and child assessment of HR‐QoL impairment was high, particularly among those for whom HR‐QoL was not impaired. During the consolidation phase, which included intensive asparaginase administration, multivariable models demonstrated more impairment in Treatment Anxiety and Procedural Anxiety for children treated with intramuscular asparaginase than intravenous asparaginase, but randomized groups were otherwise similar in HR‐QoL. Impairments in fatigue, both General and Sleep/Rest, were evident throughout and worse during intensive asparaginase therapy.Conclusions: This report examines HR‐QoL for children with ALL during treatment longitudinally by parent and patient report across multiple domains. Children with ALL demonstrated substantial impairment in HR‐QoL, particularly related to fatigue during intensive consolidation therapy including asparaginase.Keywords
This publication has 15 references indexed in Scilit:
- Physical exercise training interventions for children and young adults during and after treatment for childhood cancerCochrane Database of Systematic Reviews, 2016
- Anxiety, pain, and nausea during the treatment of standard‐risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology GroupCancer, 2016
- Asparaginase-associated toxicity in children with acute lymphoblastic leukemiaLeukemia & Lymphoma, 2015
- Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331International Journal of Cancer, 2015
- Childhood and adolescent cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Asparaginase‐associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemiaPediatric Blood & Cancer, 2012
- Health‐related quality of life among children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2012
- Quality of life in children with acute lymphoblastic leukaemia: A systematic reviewEuropean Journal of Oncology Nursing, 2009
- Literature Review: Health-related Quality of Life Measurement in Pediatric Oncology: Hearing the Voices of the ChildrenJournal of Pediatric Psychology, 2007
- The PedsQL™ in pediatric cancerCancer, 2002